Stress ulcer bleeding

被引:16
作者
Harty R.F. [1 ]
Ancha H.B. [1 ]
机构
[1] Section of Gastroenterology, Department of Medicine, Oklahoma University Medical Center, Oklahama City, OK 73104
关键词
Omeprazole; Intensive Care Unit Patient; Lansoprazole; Misoprostol; Esomeprazole;
D O I
10.1007/s11938-006-0034-3
中图分类号
学科分类号
摘要
Although upper gastrointestinal (GI) bleeding from stress-related mucosal disease (SRMD) in critically ill patients is common, significant bleeding with hemodynamic instability is not. Risk factor assessment can assist in identifying patients with a greater likelihood of developing significant SRMD. Prophylaxis against stress ulcer bleeding with luminal agents (eg, antacids and sucralfate) or drugs that inhibit acid secretion (eg, histamine 2-receptor antagonists [H2RAs] and proton-pump inhibitors [PPIs]) can reduce major bleeding but has little or no effect on mortality. Currently, the mainstays of prophylactic therapy for SRMD are intravenously administered H2RAs and PPIs. Wider usage of PPIs reflects their enhanced efficacy in suppressing acid secretion as well as lack of tolerance for H2RAs. Guidelines for the prophylactic use of H2RAs or PPIs in treatment of SRMD will require large, randomized studies that also examine cost effectiveness of individual strategies. Copyright © 2006 by Current Science Inc.
引用
收藏
页码:157 / 166
页数:9
相关论文
共 40 条
[1]  
Spechler S.J., Peptic ulcer disease and its complications, Gastrointestinal and Liver Disease, pp. 747-781, (2002)
[2]  
Haglund U., Stress ulcers, Scand J Gastroenterol, 25, SUPPL. 175, pp. 27-33, (1990)
[3]  
Lucas C.E., Sugawa C., Riddle J., Et al., Natural history and surgical dilemma of "stress" gastric bleeding, Arch Surg, 102, pp. 266-273, (1971)
[4]  
Czaja A.J., McAlhany J.C., Pruitt Jr. B.A., Acute gastroduodenal disease after thermal injury: An endoscopic evaluation of incidence and natural history, N Engl J Med, 291, pp. 925-929, (1974)
[5]  
Hastings P.R., Skillman J.J., Bushnell, Et al., Antacid titration in the prevention of acute gastrointestinal bleeding: A controlled, randomized trial in 100 critically ill patients, N Engl J Med, 298, pp. 1041-1045, (1978)
[6]  
Cook D.J., Fuller H.D., Guyatt G.H., Et al., Risk factors for gastrointestinal bleeding in critically ill patients, N Engl J Med, 330, pp. 377-381, (1994)
[7]  
Cook D.J., Reeve B.K., Guyatt G.H., Et al., Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analysis, JAMA, 275, pp. 308-314, (1996)
[8]  
Tryba M., Cook D.J., Current guidelines on stress ulcer prophylaxis, Drugs, 54, pp. 581-596, (1997)
[9]  
Stollman N., Metz D.C., Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients, J Crit Care, 20, pp. 35-45, (2005)
[10]  
Spirt M.J., Stress-related mucosal disease, Curr Treat Options Gastroenterol, 6, pp. 135-145, (2003)